CVS Health announces a new initiative focused on kidney care and home dialysis treatment

By ASN Staff

2000px-CVS_Health_logo.svg.pngOn April 4th, 2018, CVS Health “announced a new initiative focused on chronic kidney disease and dialysis, which builds upon the company's focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs. This new program will focus on early identification of kidney disease and expansion of home dialysis in order to optimize care for patients with chronic kidney disease. CVS Health's unique enterprise assets along with the company's introduction of a truly innovative new home hemodialysis technology, position the company as a positive disruptor in the field with the ability to help reshape and redefine the kidney care space.

‘In dialysis today, there is an enormous unmet medical need with high levels of mortality, frequent hospitalizations and poor quality of life for affected patients,’ said Alan Lotvin, M.D., executive vice president and head of CVS Specialty. ‘As we explored this area it became clear that our enterprise assets – from our experience with complex patient home care through Coram, the breadth of our chronic disease management capabilities with CVS Specialty and Accordant, and our deep payor relationships at CVS Caremark – will enable us to create a unique value proposition to help reshape dialysis treatment.’

‘While in-center dialysis clinics are currently the most common choice for hemodialysis treatment, published clinical research has shown improved cardiac health, metabolic control, and survival for patients who are treated with longer, more frequent dialysis treatments.  This treatment paradigm is best delivered in the convenience of a patient's home,’ said Bruce Culleton, M.D., vice president and chief medical officer, CVS Specialty. "CVS Health is uniquely positioned to build a solution that will enable us to identify and intervene earlier with patients to optimize the management of chronic kidney disease, while at the same time making home dialysis therapies a real option for more patients.’

For the full report, please read the associated press release.

Category:
Subcategory:
Author:
ASN Staff
Body:

2000px-CVS_Health_logo.svg.pngOn April 4th, 2018, CVS Health “announced a new initiative focused on chronic kidney disease and dialysis, which builds upon the company's focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs. This new program will focus on early identification of kidney disease and expansion of home dialysis in order to optimize care for patients with chronic kidney disease. CVS Health's unique enterprise assets along with the company's introduction of a truly innovative new home hemodialysis technology, position the company as a positive disruptor in the field with the ability to help reshape and redefine the kidney care space.

‘In dialysis today, there is an enormous unmet medical need with high levels of mortality, frequent hospitalizations and poor quality of life for affected patients,’ said Alan Lotvin, M.D., executive vice president and head of CVS Specialty. ‘As we explored this area it became clear that our enterprise assets – from our experience with complex patient home care through Coram, the breadth of our chronic disease management capabilities with CVS Specialty and Accordant, and our deep payor relationships at CVS Caremark – will enable us to create a unique value proposition to help reshape dialysis treatment.’

‘While in-center dialysis clinics are currently the most common choice for hemodialysis treatment, published clinical research has shown improved cardiac health, metabolic control, and survival for patients who are treated with longer, more frequent dialysis treatments.  This treatment paradigm is best delivered in the convenience of a patient's home,’ said Bruce Culleton, M.D., vice president and chief medical officer, CVS Specialty. "CVS Health is uniquely positioned to build a solution that will enable us to identify and intervene earlier with patients to optimize the management of chronic kidney disease, while at the same time making home dialysis therapies a real option for more patients.’

For the full report, please read the associated press release.

Area(s) of Interest:
Date:
Wednesday, April 11, 2018